- Report
- July 2023
- 160 Pages
Global
From €4341EUR$4,949USD£3,725GBP
- Report
- July 2023
- 160 Pages
Global
From €4341EUR$4,949USD£3,725GBP
- Report
- July 2023
- 160 Pages
Global
From €4341EUR$4,949USD£3,725GBP
- Report
- June 2023
- 140 Pages
Global
From €4341EUR$4,949USD£3,725GBP
- Report
- May 2023
- 140 Pages
Global
From €4341EUR$4,949USD£3,725GBP
- Report
- May 2023
- 140 Pages
Global
From €4341EUR$4,949USD£3,725GBP
- Report
- May 2023
- 147 Pages
Global
From €4341EUR$4,949USD£3,725GBP
- Report
- April 2023
- 147 Pages
Global
From €4341EUR$4,949USD£3,725GBP
- Report
- November 2023
- 55 Pages
Global
From €2193EUR$2,500USD£1,882GBP
- Report
- June 2024
- 437 Pages
Global
From €3903EUR$4,450USD£3,350GBP
- Report
- April 2024
- 94 Pages
Africa, Middle East
From €3026EUR$3,450USD£2,597GBP
- Report
- April 2024
- 87 Pages
From €3026EUR$3,450USD£2,597GBP
- Report
- April 2024
- 106 Pages
Asia Pacific
From €3026EUR$3,450USD£2,597GBP
- Report
- April 2024
- 107 Pages
Europe
From €3026EUR$3,450USD£2,597GBP
- Report
- April 2024
- 96 Pages
North America
From €3026EUR$3,450USD£2,597GBP
- Report
- November 2023
- 106 Pages
North America
From €3026EUR$3,450USD£2,597GBP
- Report
- November 2023
- 100 Pages
Africa, Middle East
From €3026EUR$3,450USD£2,597GBP
- Report
- November 2023
- 98 Pages
From €3026EUR$3,450USD£2,597GBP
- Report
- November 2023
- 114 Pages
Europe
From €3026EUR$3,450USD£2,597GBP
- Report
- November 2023
- 112 Pages
Asia Pacific
From €3026EUR$3,450USD£2,597GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more